The Child and Adolescent NeuroDevelopment Initiative

Investigational Drug Study for Adolescents and Adults with Fragile X Syndrome is a research study of an investigational drug for adolescents and adult males between ages 14 and 40 diagnosed with Fragile X Syndrome.

We are looking for 8 more subjects with Fragile X Syndrome diagnosis to participate in this research study.

The Child and Adolescent NeuroDevelopment Initiative (CANDI) is a research program in the Department of Psychiatry at the University of Massachusetts Medical School dedicated to neuroimaging and treatment studies of individuals with mood disorders, trauma, and developmental disabilities including autism and fragile X. Led by Jean Frazier, MD, Vice Chair for Child and Adolescent Psychiatry at the University of Massachusetts Medical School and David N. Kennedy, PhD, Professor of Psychiatry at the University of Massachusetts Medical School, CANDI is one of few research sites in the country committed to working with children and adolescents with some of the most severe behavioral and emotional challenges.

 About CANDI Button  Studies Button  Family Resources Button

CANDI logo  Find us on Facebook and Twitter.